|
Oncogenes and Tumor Suppressors
Citations 281-290 of 795 total displayed.
|
Past content
(since May 2000):
|
T-cell non-Hodgkin lymphoma
- Mujahid A. Rizvi, Andrew M. Evens, Martin S. Tallman, Beverly P. Nelson, and Steven T. Rosen
Blood 2006; 107: 1255-1264.
[Abstract]
[Full text]
[PDF]
Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells
- Bing Z. Carter, Duncan H. Mak, Wendy D. Schober, Maria Cabreira-Hansen, Miloslav Beran, Teresa McQueen, Wenjing Chen, and Michael Andreeff
Blood 2006; 107: 1555-1563.
[Abstract]
[Full text]
[PDF]
BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B
- Alessandra Aloisi, Sandra Di Gregorio, Fabio Stagno, Patrizia Guglielmo, Francesca Mannino, Maria Pia Sormani, Paolo Bruzzi, Carlo Gambacorti-Passerini, Giuseppe Saglio, Salvatore Venuta, Rosario Giustolisi, Angelo Messina, and Paolo Vigneri
Blood 2006; 107: 1591-1598.
[Abstract]
[Full text]
[PDF]
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
- Ofer Margalit, Hila Amram, Ninette Amariglio, Amos J. Simon, Sigal Shaklai, Galit Granot, Neri Minsky, Avichai Shimoni, Alon Harmelin, David Givol, Mordechai Shohat, Moshe Oren, and Gideon Rechavi
Blood 2006; 107: 1599-1607.
[Abstract]
[Full text]
[PDF]
VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease
- Rita Fragoso, Teresa Pereira, Yan Wu, Zhenping Zhu, José Cabeçadas, and Sérgio Dias
Blood 2006; 107: 1608-1616.
[Abstract]
[Full text]
[PDF]
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells
- Weihua Wan, Mark S. Albom, Lihui Lu, Matthew R. Quail, Nadine C. Becknell, Linda R. Weinberg, Dandu R. Reddy, Beverly P. Holskin, Thelma S. Angeles, Ted L. Underiner, Sheryl L. Meyer, Robert L. Hudkins, Bruce D. Dorsey, Mark A. Ator, Bruce A. Ruggeri, and Mangeng Cheng
Blood 2006; 107: 1617-1623.
[Abstract]
[Full text]
[PDF]
The ETS factor TEL2 is a hematopoietic oncoprotein
- Cintia Carella, Mark Potter, Jacqueline Bonten, Jerold E. Rehg, Geoffrey Neale, and Gerard C. Grosveld
Blood 2006; 107: 1124-1132.
[Abstract]
[Full text]
[PDF]
Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4
- Christian Kardinal, Marc Dangers, Angelika Kardinal, Alexandra Koch, Dominique Tobias Brandt, Teruko Tamura, and Karl Welte
Blood 2006; 107: 1133-1140.
[Abstract]
[Full text]
[PDF]
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
- Roberto Piva, Roberto Chiarle, Andrea D. Manazza, Riccardo Taulli, William Simmons, Chiara Ambrogio, Valentina D'Escamard, Elisa Pellegrino, Carola Ponzetto, Giorgio Palestro, and Giorgio Inghirami
Blood 2006; 107: 689-697.
[Abstract]
[Full text]
[PDF]
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia
- Wei Liu, Meng Guo, Ya-Bei Xu, Dao Li, Zhao-Nian Zhou, Ying-Li Wu, Zhu Chen, Scott C. Kogan, and Guo-Qiang Chen
Blood 2006; 107: 698-707.
[Abstract]
[Full text]
[PDF]
|
|
